Here's Why Ercros (BME:ECR) Has A Meaningful Debt Burden

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the permanent loss of capital.' So it might be obvious that you need to consider debt, when you think about how risky any given stock is, because too much debt can sink a company. We can see that Ercros, S.A. (BME:ECR) does use debt in its business. But the real question is whether this debt is making the company risky.

Advertisement

Why Does Debt Bring Risk?

Debt assists a business until the business has trouble paying it off, either with new capital or with free cash flow. If things get really bad, the lenders can take control of the business. However, a more usual (but still expensive) situation is where a company must dilute shareholders at a cheap share price simply to get debt under control. Of course, plenty of companies use debt to fund growth, without any negative consequences. When we think about a company's use of debt, we first look at cash and debt together.

Check out our latest analysis for Ercros

What Is Ercros's Debt?

You can click the graphic below for the historical numbers, but it shows that as of June 2023 Ercros had €130.5m of debt, an increase on €109.2m, over one year. However, because it has a cash reserve of €32.6m, its net debt is less, at about €97.9m.

debt-equity-history-analysis
BME:ECR Debt to Equity History November 10th 2023

A Look At Ercros' Liabilities

According to the last reported balance sheet, Ercros had liabilities of €183.2m due within 12 months, and liabilities of €170.4m due beyond 12 months. Offsetting these obligations, it had cash of €32.6m as well as receivables valued at €113.1m due within 12 months. So its liabilities total €207.9m more than the combination of its cash and short-term receivables.

This deficit is considerable relative to its market capitalization of €244.1m, so it does suggest shareholders should keep an eye on Ercros' use of debt. This suggests shareholders would be heavily diluted if the company needed to shore up its balance sheet in a hurry.

We measure a company's debt load relative to its earnings power by looking at its net debt divided by its earnings before interest, tax, depreciation, and amortization (EBITDA) and by calculating how easily its earnings before interest and tax (EBIT) cover its interest expense (interest cover). This way, we consider both the absolute quantum of the debt, as well as the interest rates paid on it.

Ercros has a low net debt to EBITDA ratio of only 1.4. And its EBIT easily covers its interest expense, being 11.5 times the size. So you could argue it is no more threatened by its debt than an elephant is by a mouse. It is just as well that Ercros's load is not too heavy, because its EBIT was down 50% over the last year. When a company sees its earnings tank, it can sometimes find its relationships with its lenders turn sour. The balance sheet is clearly the area to focus on when you are analysing debt. But it is future earnings, more than anything, that will determine Ercros's ability to maintain a healthy balance sheet going forward. So if you want to see what the professionals think, you might find this free report on analyst profit forecasts to be interesting.

Finally, a company can only pay off debt with cold hard cash, not accounting profits. So it's worth checking how much of that EBIT is backed by free cash flow. Over the most recent three years, Ercros recorded free cash flow worth 58% of its EBIT, which is around normal, given free cash flow excludes interest and tax. This free cash flow puts the company in a good position to pay down debt, when appropriate.

Our View

Ercros's struggle to grow its EBIT had us second guessing its balance sheet strength, but the other data-points we considered were relatively redeeming. In particular, its interest cover was re-invigorating. Taking the abovementioned factors together we do think Ercros's debt poses some risks to the business. While that debt can boost returns, we think the company has enough leverage now. When analysing debt levels, the balance sheet is the obvious place to start. But ultimately, every company can contain risks that exist outside of the balance sheet. Case in point: We've spotted 3 warning signs for Ercros you should be aware of, and 1 of them is significant.

Of course, if you're the type of investor who prefers buying stocks without the burden of debt, then don't hesitate to discover our exclusive list of net cash growth stocks, today.

Valuation is complex, but we're here to simplify it.

Discover if Ercros might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About BME:ECR

Ercros

Manufactures and sells chemical and pharmaceutical products in Spain and internationally.

Reasonable growth potential and fair value.

Advertisement

Weekly Picks

JO
Jolt_Communications
ZENA logo
Jolt_Communications on ZenaTech ·

ZenaTech: A big bet on the rise of AI drones and drones-as-a-service

Fair Value:US$6.8566.1% undervalued
20 users have followed this narrative
0 users have commented on this narrative
1 users have liked this narrative
TR
tripledub
INTU logo
tripledub on Intuit ·

A Wonderful Business at a Not-So-Wonderful Price

Fair Value:US$50013.5% undervalued
18 users have followed this narrative
0 users have commented on this narrative
17 users have liked this narrative
FA
A1AKK logo
FA_Trader on A1 A.K. Koh Group Berhad ·

A1 A.K. Koh Group Berhad: A simple local food story that could ride on Visit Malaysia 2026

Fair Value:RM 0.3340.9% undervalued
7 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
KA
AII logo
kaladorm on American Integrity Insurance Group ·

Priced for worse weather, but undervalued even for a high hurricane season

Fair Value:US$37.1948.9% undervalued
9 users have followed this narrative
0 users have commented on this narrative
3 users have liked this narrative

Updated Narratives

MR
MRT23
GIII logo
MRT23 on G-III Apparel Group ·

Fair Value of $40 for G-III Apparel Group Anticipated Over 5 Years

Fair Value:US$4032.8% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
MR
MRT23
PR logo
MRT23 on Permian Resources ·

PR is a low-cost Delaware Basin consolidator offering investors a capital-efficient, growing free cash flow stream with conservative leverag

Fair Value:US$2514.2% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
MR
MRT23
FISV logo
MRT23 on Fiserv ·

Fiserv is a high-switching-cost payments infrastructure business at fair value under even pessimistic assumptions.

Fair Value:US$11551.7% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

YA
SOFI logo
Yang_ on SoFi Technologies ·

SoFi Technologies: The Apex Aggregator and the Infrastructure of the Modern Financial System

Fair Value:US$22.9830.9% undervalued
49 users have followed this narrative
0 users have commented on this narrative
36 users have liked this narrative
PD
VRT logo
pdixit1 on Vertiv Holdings Co ·

The Infrastructure AI Cannot Be Built Without

Fair Value:US$408.6438.2% undervalued
39 users have followed this narrative
3 users have commented on this narrative
18 users have liked this narrative
ZA
PME logo
ZayaanS on Pro Medicus ·

Pro Medicus: The Market Is Confusing a Lumpy Quarter With a Broken Business

Fair Value:AU$196.7839.3% undervalued
33 users have followed this narrative
7 users have commented on this narrative
21 users have liked this narrative